IMMUNOLOGY LETTERS

投稿咨询

官方网站：http://www.journals.elsevier.com/immunology-letters/

投稿网址：http://ees.elsevier.com/imlet/default.asp?acw=8

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0165-2478%5BISSN%5D

《免疫学快报》提供了一种快速出版长篇和短篇文章、快速笔记、(迷你)评论和给编辑的信件的工具，这些信件涉及分子和细胞免疫学的所有方面。出版的基本标准将是清晰、实验的健全和新颖。与当前公认的想法相矛盾的结果或与实际教条相背离的想法，只要它们是基于坚实的实验结果，将被考虑发表。优先考虑对其他研究者具有直接重要性的论文，无论是通过他们的实验数据、新观点还是新方法。与已发表论文有关的科学函电也可接受，但必须简短，并与所述论文有科学上的联系，以便提供一个继续讨论的论坛。在参考区，考虑发表功能未知的新mRNA序列、具有组织分布的表达序列标记和新的单克隆抗体描述。

Immunology Letters provides a vehicle for the speedy publication of full-length and short articles, Rapid Notes, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings. Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion. Within a reference section, new mRNA sequences with unknown function, expressed sequence tags with tissue distribution and novel monoclonal antibody descriptions are considered for publication.